ABSTRACT After the death from massive haemoptysis of two neutropenic patients who had developed apparent pulmonary mycetomas, two subsequent patients underwent successful resection ofsimilar lesions. Histological examination ofthese lesions confirmed that these so called mycetomas were masses of devitalised lung tissue infiltrated with fungus. The term mycotic lung sequestrum is therefore proposed to distinguish this condition from a fungus ball arising in a previously formed cavity. A review of 34 similar cases reported previously showed that haemoptysis occurred in about half of the cases and was fatal in just over half of these. Medical treatment appears to have little impact on survival and early consideration of surgical intervention is important.
Invasive pulmonary aspergillosis is a major cause of death in neutropenic patients. ' Evidence ofit has been found at necropsy in up to 20% of patients dying with acute leukaemia.2 More recently invasive pulmonary aspergillosis has been diagnosed in life in 21% of patients undergoing treatment for acute leukaemia, and 67% of these died within two months of diagnosis of the fungal infection. 3 The range of manifestations of invasive pulmonary aspergillosis has been reported in several large series of cases.45 The most common clinical and histological manifestations were necrotising bronchopneumonia and haemorrhagic pulmonary infarction, occurring in about 60% of cases. Recently, however, apparent mycetoma formation (seen on radiographs as an air crescent surrounding a dense opacity but differing histologically from the classical mycetoma occurring in patients with pre-existing lung disease) has been increasingly described. Since the aetiology and management of this syndrome is controversial we describe our experience with four such patients and review 34 published cases in an attempt to resolve these issues.
Patients and methods
Nine cases of invasive pulmonary aspergillosis have been diagnosed before death among patients undergoAddress for reprint requests: Dr C C Kibbler, Department of Clinical Microbiology, University College Hospital, London WC I E 6AU. Accepted 18 November 1987 ing treatment in the haematology unit in the past 18 months. Two of the nine patients had radiological evidence of apparent mycetoma formation. The management of these two patients was influenced by the clinical course of two similar patients who had both died from massive haemoptysis. Brief case reports of all four patients are presented.
We reviewed the available publications on invasive pulmonary aspergillosis occurring in neutropenic patients and progressing to mycetoma formation.""'4
From this we extracted the following data: underlying disease, date of onset and duration of neutropenia, surgical intervention and outcome, haemoptysis (life threatening or otherwise), antifungal treatment, serological evidence of aspergillus infection, and duration of survival. Cases appearing in more than one publication were included once only. Some reports that described patients with apparent pulmonary mycetomas gave insufficient detail to enable the cases to be included in this survey.415
Case reports Details of the four patients are shown in table 1 . All patients had a normal chest radiograph before the onset of neutropenia (neutrophils <1-0 x 109/1), which in the first two cases followed chemotherapy and total body irradiation as conditioning for allogeneic bone marrow transplantation. The other two patients became neutropenic after induction treatment for acute leukaemia. Localised shadowing appeared on the chest radiograph in three patients after the Apparent pulmonary mycetomafollowing invasive aspergillosis in neutropenic patients onset of neutropenia. Patient 4 was febrile for seven days but did not develop radiological evidence of infection until six days after resolution of neutropenia. Three of the four patients became afebrile after starting treatment with broad spectrum antibiotics, which initially suggested a bacterial pneumonia; and indeed in patient 3 Klebsiella pneumoniae was grown from bronchoalveolar lavage fluid and blood cultures at the onset of radiological shadowing. All four patients underwent fibreoptic bronchoscopy and lavage but, apart from the Klebsiella obtained from patient 3, only normal upper respiratory tract organisms were isolated, despite prolonged incubation of Sabouraud plates at 20°, 30°, and 37T C in an attempt to culture fungi. The radiological shadowing progressed in all patients until a single cavity appeared containing a rounded opacity (the "air crescent sign" fig 1) . Once this had occurred invasive fungal disease was suspected and treatment was started with intravenous amphotericin B.
The lesions in patients I and 2 persisted and both died of massive haemoptysis. A policy ofearly surgical intervention in future cases was therefore formulated and, as a result, resection of the affected lobe was performed 15 days after diagnosis in patient 3 and eight days in patient 4.
Patient 3 developed atrial fibrillation and an episode of pulmonary oedema after resection, but both patients were discharged well 41 days after surgery. They subsequently died in a leukaemic relapse.
Gross examination of the resected or post mortem tissues in each case showed areas suggestive of necrosis, which had a tendency to separate from the Haemoptysis occurred in 11 out of22 patients, six of whom died as a direct result. The mean time interval between radiological diagnosis of cavitation and haemoptysis was 7 (range 1-24) days.
The platelet count at the time of haemoptysis was known for six of the 11 patients in whom haemoptysis occurred and in each case was at least 26 x 109/1. The absolute platelet count can be determined for three cases, of which one was in the normal range (231 x 109/1). The clotting profiles were said to be normal in the three patients with massive haemoptysis in Albeda's series.3 In our three patients with haemoptysis the prothrombin and partial thromboplastin times were within the normal range.
Surgery was undertaken in eight patients, including three who had massive haemoptysis. Although morbidity related to surgery was not examined in any of the series, no deaths due to surgery were documented. The mean duration of survival in the four patients undergoing surgery for whom data are available was 305 (SD 177) days, compared with 246 (SD 344) days in the 18 patients treated conservatively.
Information on the infecting organism was available for only 10 patients. Seven cases were due to Aspergillusfumigatus, three to Aflavus, and one to an unidentified species of Aspergillus. Antibodies against Aspergillus species antigens were measured by various methods (aspergillus precipitins57 '12 and immunoblot analysis'6), in only 10 patients and were detectable in 7.
Details of treatment where specified are shown in table 2. There was no significant difference in duration of survival between patients given no effective antifungal therapy (mean survival 296 (SD 214) days) and those given a total dose of up to 2-0 g amphotericin (mean survival 208 (174) days).
Discussion
Attempts to examine management strategies in invasive pulmonary aspergillosis are fraught with difficulties. There is a wide range of disease and the immune status of the affected patients varies enormously. We have restricted our study to one specific presentation ofthe disease and the conclusions drawn cannot be extrapolated to other forms.
Our findings confirm that pulmonary "mycetomas" occurring in neutropenic patients with previously normal lungs consist of necrotic pulmonary tissue infiltrated with fungus.'01' 1314 Thus the term "mycetoma," implying a "fungal ball" arising within a previously formed cavity, is a misnomer. Several authors have referred to the concept of a "sequestrum" of devitalised lung tissue'" "' and we propose the term mycotic lung sequestrum to describe such a lesion.
Invasive aspergillosis characteristically affects the blood vessels, causing thrombosis and local infarction. Invasion of previously infarcted lung tissue by saprophytic fungi, including Aspergillus species, is well recognised'7 and invasion of the lung by Aspergillus could have been the consequence rather than the cause of infarction in the cases in this survey. Such a sequence ofevents is difficult to substantiate, however, in neutropenic patients, and pulmonary infarction in the absence of invasive fungal infection appears to be extremely unusual. This suggests that thrombosis and subsequent pulmonary infarction follow invasion with the fungus, rather like the progressive rhinocerebral aspergillosis seen in such patients. It is not clear why some patients develop necrotising bronchopneumonia and haemorrhagic pulmonary infarction, while others have localised disease with subsequent sequestrum formation, though invasion of particular vessels may play a part in determining the extent and pattern of necrosis. The mechanism by which the sequestrum becomes separated from surrounding normal lung might depend on neutrophil proteolytic enzyme activity as previously suggested,3 as most cases have occurred after bone marrow recovery. There are reports of cases where this did not occur, and not all patients with invasive pulmonary aspergillosis whose bone marrows regenerate form a mycotic lung sequestrum. Why certain patients form a cavity without a sequestrum is not clear. Perhaps sufficient central fungal infiltration is required to prevent resorption of the mass.
The radiological appearances suggesting mycotic lung sequestrum are not specific and the differential diagnosis has to take account of tuberculosis, nocardiasis, lung abscess due to other bacteria, hydatid disease, cysticercosis, and neoplasm.3"' Mucor species may also cause infection.'8 There are limited data on methods of diagnosis in these patients. Fibreoptic bronchoscopy yielded the diagnosis in a third of patients and antibody was detected in seven out of 10. The radiological features may be the best guide to diagnosis in most patients. The organism was grown from tissue either before or after death in only half the cases, suggesting that, even with bronchoscopy, attempts at a diagnosis based on culture alone are likely to be inadequate. Failure to culture the organism may have been due to prior treatment with antifungal agents in some cases, but Aspergillus could not be cultured from 30% of tissue specimens in a series where most patients were untreated. 4 This review shows that haemoptysis is life threatening in this condition and in most cases occurs within one week of diagnosis. There is no way of predicting III 112 which patients are at risk, thought premonitory haemoptysis occurs in a small number.
Once the patient has survived the initial risk period the best guide to prognosis would appear to be the state of the bone marrow. There were at least five cases in which spontaneous resolution occurred without effective treatment. Unfortunately, the patients who die during the initial period usually do so when in remission and hence would otherwise have had a relatively good prognosis. Since there was no evidence that antifungal treatment improved survival we recommend surgical intervention when possible. The results of the survey suggest that resection should take place as soon as possible after diagnosis, preferably within the first week. Surgery was not associated with major problems in the eight patients in whom it was carried out, presumably because they were no longer appreciably neutropenic or thrombocytopenic and were relatively young and fit, apart from their underlying disease. A survey of published cases is of necessity incomplete and there may well be unpublished cases of mycotic lung sequestrum in which surgery has been associated with death. Surgery in patients with aspergilloma has been estimated to carry a mortality of 8%'9; but these patients are usually older, with underlying lung disease.
In conclusion, we believe that a neutropenic patient developing pneumonia should receive intravenous amphotericin B (1 0-1 .5 mg/kg a day) in the absence of a response to broad spectrum antibiotics while serological investigation and, if possible, fibreoptic bronchoscopy with bronchoalveolar lavage is undertaken. The patient must be carefully monitored with frequent chest radiographs, particularly after marrow regeneration. At the first suspicion of cavitation tomography should be undertaken, and if this shows the appearances of mycotic lung sequestrum formation a surgical opinion is advised.
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